Nexonlife Remedies India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 20.00 K
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
About Nexonlife Remedies India
Nexonlife Remedies India Private Limited (NRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2022 (Two years and one month 16 days old ). Its registered office is in Bargarh, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 20.00 K .
The company currently has active open charges totaling ₹1.00 M.
Lambodar Mahapatra and Sagarika Mahapatra serve as directors at the Company.
Company Details
-
Location
Bargarh, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100OR2022PTC041536
-
Company No.
041536
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Dec 2022
-
Date of AGM
30 Jun 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Nexonlife Remedies India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lambodar Mahapatra
|
Director | 23-Dec-2022 | Current |
|
Sagarika Mahapatra
|
Director | 23-Dec-2022 | Current |
Financial Performance of Nexonlife Remedies India.
Nexonlife Remedies India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexonlife Remedies India?
Unlock access to Nexonlife Remedies India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2023 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Nexonlife Remedies India?
Unlock and access historical data on people associated with Nexonlife Remedies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexonlife Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexonlife Remedies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.